Pfizer

Pfizer/BioNTech’s Comirnaty (tozinameran) is forecast to have peak sales of $24.8bn by 2021, which is only its second year on the…

Several allergic reaction incidents, including serious episodes, known as anaphylaxis, have been reported in the US after…

Whether COVID-19 vaccines work and are safe to use on children is one of the big questions drugmakers are trying to answer

The risk of infection fell 90 per cent by two weeks after the second shot, the study of nearly 4,000 US healthcare personnel and…

Pfizer withdrew an application last month seeking EUA for its product in India after the DCGI declined its request to skip a small…

Pfizer and Moderna are already working on developing booster shots for their vaccines to improve their effectiveness against the…

The scientists said the neutralising ability was roughly equivalent to the vaccine’s effect on a previous less contagious version…

The accelerated process is based on that used for seasonal flu vaccines each year, said MHRA

Approval is based on CROWN trial, which showed a 72 per cent reduction in risk of progression or death for treatment with LORBRENA…

Britain now aims to give the first dose to all over-50s by April 15, the government said